SPC190
Ixasómíb og lyfjafræðilega hæf sölt og esterar þar af, á borð við ixasómíbsítrat
Status:
VeittApplication date:
5.4.2017Application published:
15.5.2017Grant published:
15.8.2018
Max expiry date:
22.11.2031Medicine name:
NinlaroMedicine for children:
No
Timeline
Today
5.4.2017Application
15.5.2017Publication
15.8.2018Registration
22.11.2031Expires
Marketing license
IS authorization number:
EU/1/16/1094/002; EU/1/16/1094/003; EU/1/16/1094/001Date:
7.12.2016
Foreign authorization number:
EU/1/16/1094Date:
21.11.2016
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645 JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2178888